Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter to the Editor - Case Letter
2017:83:2;224-226
doi: 10.4103/0378-6323.198452
PMID: 28164890

A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms

Wafa Saidi, Ines Lahouel, Molka Laarif, Amina Aounallah
 Department of Dermatology, Farhat Hached Hospital, University of Sousse, Sousse, Tunisia

Correspondence Address:
Ines Lahouel
Department of Dermatology, Farhat Hached Hospital, 4000 Sousse
Tunisia
How to cite this article:
Saidi W, Lahouel I, Laarif M, Aounallah A. A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms. Indian J Dermatol Venereol Leprol 2017;83:224-226
Copyright: (C)2017 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Imatinib mesylate is an inhibitor of tyrosine kinases. It is approved for the treatment of chronic myeloid leukemia. The most commonly reported adverse reactions are maculopapular eruptions and periorbital edema. Severe adverse reactions are seen in 5% of patients.[1] We were able to find only three previous reports of drug-induced reaction with eosinophilia and systemic symptoms (DRESS) caused by imatinib.[2],[3],[4]

A 53-year-old woman was diagnosed with chronic myeloid leukemia. Initially, the patient had been treated with hydroxyurea along with allopurinol, since December 27, 2013. On March 13, 2014, hydroxyurea and allopurinol were stopped and imatinib, 400 mg daily was introduced. Nineteen days after starting imatinib, the patient presented with fever and a generalized rash associated with oral erosions, facial oedema [Figure - 1] and cervical and axillary lymphadenopathy. There had been no history of any other recent drug intake. The laboratory findings were notable for leukocytosis, with a white blood cell count up to 18,700/µL and eosinophilia of 10,100/µL. Her creatine phosphokinase level was elevated at 576 IU/L. She had increased levels of urea (10 mmol/L) (normal = 3.3-7) and creatinine (102 µmol/L) (n = 53-90). The liver enzyme levels were normal. The serological tests for Epstein-Barr virus, human herpesvirus 6 and human immunodeficiency virus were negative. Skin biopsy showed a discrete parakeratosis, acanthosis, significant spongiosis, dermal edema and a perivascular inflammatory infiltrate consisting of mainly eosinophils and lymphocytes [Figure - 2] and [Figure - 3].

Figure 1: Erythematous facial edema
Figure 2: Parakeratosis, acanthosis, spongiosis with an inflammatory infiltrate (H and E, ×400)
Figure 3: Parakeratosis, acanthosis, spongiosis with an inflammatory infiltrate consisting of lymphocytes and mainly eosinophils (arrow) (H and E, ×1000)

The patient was diagnosed to have drug-induced reaction with eosinophilia and systemic symptoms (DRESS) syndrome, based on the following criteria: rash on more than 50% of her body, lymphadenopathy, eosinophilia, muscular and renal involvement. Imatinib was stopped and the patient was prescribed oral antihistamines and topical steroids. Improvement was noted with decreased erythema on the 4th day. The rash disappeared completely within 2 weeks. Renal function tests, muscle enzymes and eosinophil level normalized by the 8th day after discontinuation of imatinib. The patient was changed to an alternative anti-chronic myeloid leukemia medication, nilotinib. Reintroduction or desensitization was not attempted as drug-induced reaction with eosinophilia and systemic symptoms (DRESS) syndrome is considered a severe form of drug reaction.

Cutaneous toxicity due to imatinib is, in most cases, mild. Severe responses were reported in 5% of patients.[1] The most commonly reported adverse responses are maculopapular eruptions, periorbital edema and the less common ones include Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, hypopigmentation, lichenoid reaction, pityriasis rosea and Sweet syndrome.[1]

We were able to find three previous reports of drug-induced reaction with eosinophilia and systemic symptoms (DRESS) caused by imatinib.[2],[3],[4] The three patients had chronic myeloid leukemia. Drug-induced reaction with eosinophilia and systemic symptoms usually occurs within two to 6 weeks of introducing the drug.[3] In our patient, the rash appeared 19 days after introducing imatinib; hydroxyurea and allopurinol were stopped 3 weeks before the onset of the eruption. The mean plasma half-life of allopurinol ranges from 1 to 2 h. Allopurinol is metabolized to oxypurinol whose plasma half-life ranges from 13.6 to 29 h. After five plasma half-lives (maximum 6 days) of stopping the drug, allopurinol and its metabolites are eliminated from the body. The mean plasma half-life of hydroxyurea is short (6 h). This makes it unlikely that allopurinol or hydroxyurea were the cause of the drug eruption.

The clinical improvement and disappearance of eosinophilia were observed after stopping imatinib. According to the objective causality assessment by the Naranjo probability scale, imatinib-induced drug-induced reaction with eosinophilia and systemic symptoms was probable in our case.[5]

Drug-induced reaction with eosinophilia and systemic symptoms (DRESS) is a severe idiosyncratic reaction. Its physiopathology is not clear. Viral agents are suspected as triggering factors.[3] In our case, the viral serology did not show any active infection.

Most rashes due to imatinib are self-limiting and do not require discontinuation of treatment.[1] Oral antihistamines and topical steroids are sufficient in most cases. In two reports of drug-induced reaction with eosinophilia and systemic symptoms (DRESS) caused by imatinib, the course was favorable a few days after cessation of the drug.[2],[3] Only one case required systemic steroids and the patient was treated with oral prednisolone 1 mg/kg/day.[4] In our case, because of the absence of severe visceral involvement, we opted for topical steroids. The rash disappeared completely within 2 weeks. Le Nouail et al. also reported that the rash and associated manifestations improved within 12 days after introduction of topical steroids, as seen in our case.[3]

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Scheinfeld N. Imatinib mesylate and dermatology part 2: A review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol 2006;5:228-31.
[Google Scholar]
2.
Goldman J, Duval-Modeste AB, Lambert A, Contentin N, Courville P, Musette P, et al. Imatinib-induced DRESS. Ann Dermatol Venereol 2008;135:393-6.
[Google Scholar]
3.
Le Nouail P, Viseux V, Chaby G, Billet A, Denoeux JP, Lok C. Drug reaction with eosinophilia and systemic symptoms (DRESS) following imatinib therapy. Ann Dermatol Venereol 2006;133:686-8.
[Google Scholar]
4.
Kumar M, Mandal PK, Dolai TK, Bhattacharrya M. Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction. Indian Dermatol Online J 2014;5 Suppl 2:S120-2.
[Google Scholar]
5.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
[Google Scholar]

Fulltext Views
3,254

PDF downloads
1,628
Show Sections